Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CPI-482
i
Other names:
CPI-482
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Novartis
Drug class:
LSD1 inhibitor
Related drugs:
‹
SP2577 (7)
ORY-1001 (5)
INCB59872 (1)
MK-3543 (1)
4SC-202 (1)
DDP-38003 (0)
GSK2879552 (0)
SP-2509 (0)
CC-90011 (0)
SP2577 (7)
ORY-1001 (5)
INCB59872 (1)
MK-3543 (1)
4SC-202 (1)
DDP-38003 (0)
GSK2879552 (0)
SP-2509 (0)
CC-90011 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
JAK2 V617F
Acute Myelogenous Leukemia
JAK2 V617F
Acute Myelogenous Leukemia
CPI-482
Sensitive: D – Preclinical
CPI-482
Sensitive
:
D
CPI-482
Sensitive: D – Preclinical
CPI-482
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login